Alkermes (ALKS) Net Margin Growth (3y) (2013 - 2026)
Alkermes (ALKS) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.68 Bn | 40.02 Bn | 2.15 Bn | 948.00 |
| 3 | Zoetis | 32.31 Bn | 30.63 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 83.00 |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | -94.00 |
| 6 | Viatris | 18.87 Bn | 17.98 Bn | 1.46 Bn | -990.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -604.00 |
| 8 | Elanco Animal Health | 11.97 Bn | 11.44 Bn | 798.00 Mn | 1,312.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.42 Bn | 397.90 Mn | -3,829.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 692.00 |
| Mar 31, 2026 | -423.00 |
| Dec 31, 2025 | -1,595.00 |
| Dec 31, 2024 | -3,840.00 |
| Sep 30, 2024 | 973.00 |
| Jun 30, 2024 | -176.00 |
| Mar 31, 2024 | 820.00 |
| Dec 31, 2023 | 441.00 |
| Sep 30, 2023 | -1,185.00 |
| Jun 30, 2023 | 507.00 |
| Mar 31, 2023 | 300.00 |
| Dec 31, 2022 | -34,805.00 |
| Sep 30, 2022 | -197,847.00 |
| Jun 30, 2022 | -92,675.00 |
| Mar 31, 2022 | 3,032.00 |
| Dec 31, 2021 | 36.00 |
| Sep 30, 2021 | 399.00 |
| Jun 30, 2021 | 1,150.00 |
| Mar 31, 2021 | 1,885.00 |
| Dec 31, 2020 | 1,973.00 |